Cargando…
Identification of Direct Target Engagement Biomarkers for Kinase-Targeted Therapeutics
Pharmacodynamic (PD) biomarkers are an increasingly valuable tool for decision-making and prioritization of lead compounds during preclinical and clinical studies as they link drug-target inhibition in cells with biological activity. They are of particular importance for novel, first-in-class mechan...
Autores principales: | Paweletz, Cloud P., Andersen, Jannik N., Pollock, Roy, Nagashima, Kumiko, Hayashi, Mansuo L., Yu, Shangshuan U., Guo, Hongbo, Bobkova, Ekaterina V., Xu, Zangwei, Northrup, Alan, Blume-Jensen, Peter, Hendrickson, Ronald C., Chi, An |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200335/ https://www.ncbi.nlm.nih.gov/pubmed/22039492 http://dx.doi.org/10.1371/journal.pone.0026459 |
Ejemplares similares
-
A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors
por: Loboda, Andrey, et al.
Publicado: (2010) -
Cell-Free DNA in Oncology: Gearing up for Clinic
por: Ulrich, Bryan C., et al.
Publicado: (2018) -
Resistance to kinase inhibition through shortened target engagement
por: Rangwala, Aziz M., et al.
Publicado: (2022) -
Preliminary Evidence of Efficacy and Target Engagement of Pramipexole in Anhedonic Depression
por: Ventorp, Filip, et al.
Publicado: (2022) -
Monitoring drug–target interactions through target engagement-mediated amplification on arrays and in situ
por: Al-Amin, Rasel A, et al.
Publicado: (2022)